Anticancer activity of (±)-kusunokinin derivatives as a new HSP90 inhibitor

Simple item page
dc.contributor.authorRattanaburee T.
dc.contributor.authorThongpanchang T.
dc.contributor.authorChompunud Na Ayudhya C.
dc.contributor.authorTipmanee V.
dc.contributor.authorGraidist P.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:42:14Z
dc.date.available2023-06-18T17:42:14Z
dc.date.issued2022-10-01
dc.identifier.citationEuropean Journal of Cancer Vol.174 (2022) , S73
dc.identifier.doi10.1016/S0959-8049(22)00996-0
dc.identifier.eissn18790852
dc.identifier.issn09598049
dc.identifier.scopus2-s2.0-85144030756
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/85460
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleAnticancer activity of (±)-kusunokinin derivatives as a new HSP90 inhibitor
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85144030756&origin=inward
oaire.citation.titleEuropean Journal of Cancer
oaire.citation.volume174
oairecerif.author.affiliationFaculty of Medicine, Prince of Songkia University
oairecerif.author.affiliationMahidol University

Files

Collections

Scopus 2022